Abstract: A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as BL172 and transcribed from urinary tract tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, in vivo imaging, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the urinary tract, such as urinary tract cancer. Also provided are antibodies which specifically bind to BL172-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific BL172 polypeptide, which molecules are useful for the therapeutic treatment of urinary tract diseases, tumors or metastases.

Abstract: A black light shield for preventing incident light from being received by light receiving elements, the black shield includes a support structure; a first CrOx layer disposed over the support structure for absorbing the incident light in a substantially reflected transmission path; and a second CrOx layer disposed integral with the support structure for absorbing the incident light in a substantially non-reflected transmission path.

Abstract: An extensible project system for software development is provided by allowing a flavor, with a specific purpose, to be applied to a base project system. More than one flavor may be applied. Where components are distributed objects, such as where COM (component object model) is used, the project system is assembled by aggregation of a base project object, which contains some data for creating a project system with a flavor object, which modifies the project system. The base project object is the participating object in the aggregation and the flavor object is the controlling object. Multiple flavors may be applied to create a project system intended for multiple purposes, corresponding to the applied flavors.

Abstract: A versioning policy included in a target component indicates how the target component is to be accessed, for example, either as a library component or a platform component. A component may be designated as a library component when it is not versioned in a binary compatible manner. When other components request such a component they receive specifically the version of the component they requested. On the other hand, a component may be designated as a platform component when it is versioned in a binary compatible manner. When other components request such a component they may receive the latest upgraded version of the component requested instead. Thus, access to an appropriate version of the component (even a version differing from the requested version) is facilitated. Other embodiments include mechanisms for stratifying component scope based on different processing levels.

Abstract: A source code editor is used to develop multilanguage documents while providing the advanced editing functionality of secondary editors and without requiring the programmer to explicitly open and interface with the secondary editors. The multilanguage document is presented to the user in a primary application view of the primary editor. Code segments written in different languages are identified and sent to the appropriate secondary editors, which in turn create secondary documents that are transparent to the programmer. As edits are made to the primary application view of the document, the edits are replicated by the secondary editors behind the scene. Functionality that is enabled by the secondary editors, such as syntax coloring, auto-completion, and validation is identified by the primary editor and replicated in the primary application view, so as to appear as if the primary editor is inherently configured with the leveraged functionality of the secondary editors.

Abstract: A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as PS116 and transcribed from prostate tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, in vivo imaging, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the prostate, such as prostate cancer. Also provided are antibodies which specifically bind to PS116-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific PS116 polypeptide, which molecules are useful for the therapeutic treatment of prostate diseases, tumors or metastases.

Abstract: A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as CS141 and transcribed from GI tract tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the GI tract, such as GI tract cancer. Also provided are antibodies which specifically bind to CS141-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific CS141 polypeptide, which molecules are useful for the therapeutic treatment of GI tract diseases, tumors or metastases.

Abstract: Specific tasks associated with debugging are performed in the background, prior to a user of an application development tool invoking the debugger. The tasks including (1) starting a hosting process, (2) loading a hosted runtime environment (e.g., .NET runtime) in the process, and (3) attaching a debugger to the hosting process, are performed in the background before the user commences debugging. Once the user invokes the debugger, the user's application is executed and debugged. Thus, the perceived time to start debugging is greatly reduced.

Abstract: A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as BU101 and transcribed from breast tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, in vivo imaging, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the breast, such as breast cancer. Also provided are antibodies which specifically bind to BU101-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific BU101 polypeptide, which molecules are useful for the therapeutic treatment of breast diseases, tumors or metastases.

Abstract: A set of contiguous and partially overlapping RNA sequences and polypeptides encoded thereby, designated as PS112 and transcribed from prostate tissue is described. A fully sequenced clone representing a continuous sequence of PS112 is also disclosed. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the prostate, such as prostate cancer. Also provided are antibodies which specifically bind to PS112-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific PS112 polypeptide, which molecules are useful for the therapeutic treatment of prostate diseases, tumors or metastases.

Abstract: The present invention provides novel condensation aerosols for the treatment of disease and/or intermittent or acute conditions. These condensation aerosols have little or no pyrolysis degradation products and are characterized by having an MMAD of between 1-3 microns. These aerosols are made by rapidly heating a substrate coated with a thin film of drug having a thickness of between 0.05 and 20 &mgr;m, while passing a gas over the film, to form particles of a desirable particle size for inhalation. Kits comprising a drug and a device for producing a condensation aerosol are also provided. The device contained in the kit typically, has an element for heating the drug which is coated as a film on the substrate and contains a therapeutically effective dose of a drug when the drug is administered in aerosol form, and an element allowing the vapor to cool to form an aerosol. Also disclosed, are methods for using these aerosols and kits.

Abstract: A device for delivering a drug by inhalation is disclosed. The device includes a body defining an interior flow-through chamber having upstream and downstream chamber openings, and a drug supply unit contained within the chamber for producing, upon actuation, a heated drug vapor in a condensation region of the chamber. Gas drawn through the chamber region at a selected gas-flow rate is effective to form drug condensation particles from the drug vapor having a selected MMAD between 0.02 and 0.1 MMAD or between 1 and 3.5 &mgr;m. A gas-flow control valve disposed upstream of the unit functions to limit gas-flow rate through the condensation region to the selected gas-flow rate. An actuation switch in the device activates the drug-supply unit, such that the drug-supply unit can be controlled to produce vapor when the gas-flow rate through the chamber is at the selected flow rate.

Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to the delivery of drug containing aerosols having particles with a mass median aerodynamic diameter less than 1&mgr; for inhalation therapy. In an aspect of the present invention the drug containing aerosol comprises particles having a mass median aerodynamic diameter between 10 nm and 1&mgr;. Preferably, the particles have a mass median aerodynamic diameter between 10 nm and 900 nm. More preferably, the particles have a mass median aerodynamic diameter between 10 nm and 800 nm, 10 nm and 700 nm, 10 nm and 600 nm, 10 nm and 500 nm, 10 nm and 400 nm, 10 nm and 300 nm, 10 nm and 200 nm, or 10 nm and 100 nm.

Abstract: A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as BS200 and transcribed from breast tissue, is described. These sequences are useful for the detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the breast, such as breast cancer. Also provided are antibodies which specifically bind to BS200-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific BS200 polypeptide, which molecules are useful for the therapeutic treatment of breast diseases, tumors or metastases.

Abstract: A black light shield for preventing incident light from being received by light receiving elements, the black shield includes a support structure; a first CrOx layer disposed over the support structure for absorbing the incident light in a substantially reflected transmission path; and a second CrOx layer disposed integral with the support structure for absorbing the incident light in a substantially non-reflected transmission path.

Abstract: A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as CS198 and transcribed from GI tract tissue, is described. These sequences are useful for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the GI tract, such as GI tract cancer. Also provided are antibodies which specifically bind to CS198-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific CS198 polypeptide, which molecules are useful for the therapeutic treatment of GI tract diseases, tumors or metastases.

Abstract: The present invention relates to the inhalation delivery of aerosols containing small particles. Specifically, it relates to the delivery of drug containing aerosols having particles with a mass median aerodynamic diameter less than 1&mgr; for inhalation therapy. In a composition aspect of the present invention the drug containing aerosol comprises particles having a mass median aerodynamic diameter between 10 nm and 1&mgr;. Preferably, the particles have a mass median aerodynamic diameter between 10 nm and 900 nm. More preferably, the particles have a mass median aerodynamic diameter between 10 nm and 800 nm, 10 nm and 700 nm, 10 nm and 600 nm, 10 nm and 500 nm, 10 nm and 400 nm, 10 nm and 300 nm, 10 nm and 200 nm, or 10 nm and 100 nm.

Abstract: A method, system and apparatus for displaying photofinishing goods and/or services that are being offered for sale. An apparatus is provided which includes a display device for displaying photofinishing goods and/or services that are being offered for sale and a computer for controlling what is displayed on the display device. A computer software program is also provided for programming the computer so that a plurality of the photofinishing goods and/or services will be displayed on the display device and for program monitoring the sales of the photofinishing goods. The system allows for the remote reprogramming of the computer for modifying and or re-arranging the position of the photofinishing goods and/or services on the display device.

Abstract: A set of contiguous and partially overlapping cDNA sequences and polypeptides encoded thereby, designated as CS198 and transcribed from GI tract tissue, is described. These sequences are useful for detecting, diagnosing, staging, monitoring, prognosticating, preventing or treating, or determining the predisposition of an individual to diseases and conditions of the GI tract, such as GI tract cancer. Also provided are antibodies which specifically bind to CS198-encoded polypeptide or protein, and agonists or inhibitors which prevent action of the tissue-specific CS198 polypeptide, which molecules are useful for the therapeutic treatment of GI tract diseases, tumors or metastases.

Abstract: A method, system and apparatus for displaying photofinishing goods and/or services that are being offered for sale. An apparatus is provided which includes a display device for displaying photofinishing goods and/or services that are being offered for sale and a computer for controlling what is displayed on the display device. A computer software program is also provide for programming the computer so that a plurality of the photofinishing goods and/or services will be displayed on the display device and for program monitoring the sales the photofinishing goods. The system allows for the remote reprogramming of the computer for modifying and or re-arranging the position of the photofinishing goods and/or services on the display device.